Literature DB >> 11912006

Aberrant expression of apoptosis-related molecules in psoriatic epidermis.

Hidetoshi Takahashi1, Akira Manabe, Akemi Ishida-Yamamoto, Yoshio Hashimoto, Hajime Iizuka.   

Abstract

Apoptosis is a physiological form of cell death that is responsible for the deletion of cells. Epidermal keratinocytes are supposed to be regulated by cell proliferation and cell death leading to structural homeostasis. Psoriatic skin shows marked thickening of the epidermis, suggesting the imbalance of the homeostasis, which might be related to abnormal apoptotic process. We investigated the expression of various apoptosis-related molecules in the psoriatic hyperproliferative epidermis. Real time quantitative RT-PCR analyses revealed that mRNAs of Fas, Bcl-xL, Bax and ICAD (inhibitor of caspase 3-related DNase) of the psoriatic involved epidermis were increased by 4.2-, 2.8-, 2.6- and 5.6-fold, respectively, compared with the uninvolved epidermis. In contrast, Bcl-2 expression in the involved epidermis was one-third suppressed compared with the uninvolved epidermis. No significant difference in the expression of mRNAs of Fas ligand or CAD (caspase 3-related DNase) was detected between the involved and uninvolved epidermis. Western blot analysis and immunohistochemical studies showed compatible results obtained by RT-PCR analyses. Although active caspase 3 was slightly increased in the involved epidermis, apoptotic cells were marginally detected. These results indicate that psoriatic epidermis shows aberrant expression of apoptosis-related molecules representing suppressed apoptotic process, which might be related to characteristic histopathology.

Entities:  

Mesh:

Year:  2002        PMID: 11912006     DOI: 10.1016/s0923-1811(01)00162-1

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  8 in total

1.  FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.

Authors:  Liv Eidsmo; Caroline Fluur; Bence Rethi; Sofia Eriksson Ygberg; Nicolas Ruffin; Angelo De Milito; Hannah Akuffo; Francesca Chiodi
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Expression of Bcl-2 family proteins in psoriasis.

Authors:  Tanja Batinac; Gordana Zamolo; Ita Hadzisejdić; Gordana Zauhar; Gordana Brumini; Alen Ruzić; Viktor Persić
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

3.  Fas pulls the trigger on psoriasis.

Authors:  Amos Gilhar; Ron Yaniv; Bedia Assy; Sima Serafimovich; Yehuda Ullmann; Richard S Kalish
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

4.  Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures.

Authors:  Saskia Lippens; Mark Kockx; Geertrui Denecker; Michiel Knaapen; An Verheyen; Ruben Christiaen; Erwin Tschachler; Peter Vandenabeele; Wim Declercq
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 5.  The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis.

Authors:  Athanasios Mavropoulos; Eirini I Rigopoulou; Christos Liaskos; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Dev Immunol       Date:  2013-09-12

Review 6.  Apoptosis in Autoimmunological Diseases, with Particular Consideration of Molecular Aspects of Psoriasis.

Authors:  Agata Krawczyk; Joanna Miśkiewicz; Karolina Strzelec; Dominika Wcisło-Dziadecka; Barbara Strzalka-Mrozik
Journal:  Med Sci Monit       Date:  2020-06-22

7.  Elevated IL-22 in psoriasis plays an anti-apoptotic role in keratinocytes through mediating Bcl-xL/Bax.

Authors:  Bo Wang; Dan Han; Fei Li; Weikun Hou; Lijuan Wang; Liesu Meng; Kuanhou Mou; Shemin Lu; Wenhua Zhu; Yan Zhou
Journal:  Apoptosis       Date:  2020-10       Impact factor: 4.677

8.  Apoptosis and clinical severity in patients with psoriasis and HCV infection.

Authors:  Sami A Gabr; Mohamed Y Berika; Ahmad H Alghadir
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.